The SARS-CoV nucleocapsid protein: A protein with multifarious activities

Infection, Genetics and Evolution

Volumn 8, Issue 4, 2008, Pages 397-405

  Surjit, Milan ^a   Lal, Sunil K ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

Coronavirus; Nucleocapsid protein; RNA virus; SARS; SARS diagnosis; SARS CoV assembly

Indexed keywords

CAPSID PROTEIN; CELL PROTEIN; CYCLOOXYGENASE 2; DNA VACCINE; GENOMIC RNA; INTERFERON; M PROTEIN; NUCLEOCAPSID PROTEIN; PEPTIDE VACCINE; PLASMID DNA; PROTEIN ANTIBODY; RECOMBINANT PROTEIN; SEVERE ACUTE RESPIRATORY SYNDROME VACCINE; VITRONECTIN;

ANTIBODY DETECTION; APOPTOSIS; CARBOXY TERMINAL SEQUENCE; CELL CYCLE; CELLULAR IMMUNITY; CROSS REACTION; CYTOKINE PRODUCTION; DISEASE MARKER; DRUG RESEARCH; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME SYNTHESIS; EPIDEMIC; GENOME ANALYSIS; HUMAN; HUMORAL IMMUNITY; KIDNEY CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONTENT; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN RNA BINDING; PROTEIN STABILITY; PROTEIN STRUCTURE; PROTEIN SYNTHESIS INHIBITION; REVIEW; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; UPREGULATION; VACCINE PRODUCTION; VIRUS CELL INTERACTION; VIRUS GENOME;

CORONAVIRUS INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; NUCLEOCAPSID PROTEINS; PROTEIN PROCESSING, POST-TRANSLATIONAL; SARS VIRUS; VACCINES;

CORONAVIRUS; RNA VIRUSES; SARS CORONAVIRUS;

EID: 43649101455     PISSN: 15671348     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.meegid.2007.07.004     Document Type: Review

References (67)

1. Buchholz U.J., Bukreyev A., Yang L., Lamirande E.W., Murphy B.R., Subbarao K., and Collins P.L. Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 9804-9809
2. Bussmann B.M., Reiche S., Jacob L.H., Braun J.M., and Jassoy C. Antigenic and cellular localisation analysis of the severe acute respiratory syndrome coronavirus nucleocapsid protein using monoclonal antibodies. Virus Res. 122 (2006) 119-126
3. Chang W.T., Kao C.L., Chung M.Y., Chen S.C., et al. SARS exposure and emergency department workers. Emerg. Infect. Dis. 10 (2004) 1117-1119
4. Chang C.K., Sue S.C., Yu T.H., et al. Modular organization of SARS coronavirus nucleocapsid protein. J. Biomed. Sci. 13 (2006) 59-72
5. Che X.Y., Hao W., Wang Y., et al. Nucleocapsid protein as early diagnostic marker for SARS. Emerg. Infect. Dis. 10 (2004) 1947-1949
6. Chen C.Y., Chang C.K., Chang Y.W., et al. Structure of the SARS coronavirus nucleocapsid protein RNA-binding dimerization domain suggests a mechanism for helical packaging of viral RNA. J. Mol. Biol. 368 (2007) 1075-1086
7. Das D., and Suresh M.R. Copious production of SARS-CoV nucleocapsid protein employing codon optimized synthetic gene. J. Virol. Methods 137 (2006) 343-346
8. Fan Z., Zhuo Y., Tan X., et al. SARS-CoV nucleocapsid protein binds to hUbc9, a ubiquitin conjugating enzyme of the sumoylation system. J. Med. Virol. 78 (2006) 1365-1373
9. Fang X., Ye L.B., Zhang Y., et al. Nucleocapsid amino acids 211 to 254, in particular, tetrad glutamines, are essential for the interaction between the nucleocapsid and membrane proteins of SARS-associated coronavirus. J. Microbiol. 44 (2006) 577-580
10. Flego M., Di Bonito P., Ascione, et al. Generation of human antibody fragments recognizing distinct epitopes of the nucleocapsid (N) SARS-CoV protein using a phage display approach. BMC Infect. Dis. 5 (2005) 73
11. Gamble T.R., Vajdos F.F., Yoo S., et al. Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid. Cell 87 (1996) 1285-1294
12. Gao W., Tamin A., Soloff A., D'Aiuto L., Nwanegbo E., Robbins P.D., Bellini W.J., Barratt-Boyes S., and Gambotto A. Effects of a SARS-associated coronavirus vaccine in monkeys. Lancet 362 (2003) 1895-1896
13. He R., Leeson A., Andonov A., et al. Activation of AP-1 signal transduction pathway by SARS coronavirus nucleocapsid protein. Biochem. Biophys. Res. Commun. 311 (2003) 870-876
14. He R., Dobie F., Ballantine M., et al. Analysis of multimerization of the SARS coronavirus nucleocapsid protein. Biochem. Biophys. Res. Commun. 316 (2004) 476-483
15. He Q., Du Q., Lau S., et al. Characterization of monoclonal antibody against SARS coronavirus nucleocapsid antigen and development of an antigen capture ELISA. J. Virol. Methods 127 (2005) 46-53
16. Hsieh P.K., Chang S.C., Huang C.C., et al. Assembly of severe acute respiratory syndrome coronavirus RNA packaging signal into virus-like particles is nucleocapsid dependent. J. Virol. 79 (2005) 13848-13855
17. Hsueh P.R., Huang L.M., Chen P.J., et al. Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirus. Clin. Microbiol. Infect. 10 (2004) 1062-1066
18. Huang Q., Yu L., Petros A.M., et al. Structure of the N-terminal RNA-binding domain of the SARS CoV nucleocapsid protein. Biochemistry 43 (2004) 6059-6063
19. Kim T.W., Lee J.H., Hung C.F., et al. Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus. J. Virol. 78 (2004) 4638-4645
20. Kopecky-Bromberg S.A., Martinez-Sobrido L., Frieman M., et al. Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists. J. Virol. 81 (2007) 548-557
21. Krokhin O., Li Y., Andonov A., et al. Mass spectrometric characterization of proteins from the sars virus: a preliminary report. Mol. Cell Proteomics 2 (2003) 346-356
22. Leung D.T., van Maren W.W., Chan F.K., Chan W.S., Lo A.W., Ma C.H., Tam F.C., To K.F., Chan P.K., Sung J.J., and Lim P.L. Extremely low exposure of a community to severe acute respiratory syndrome coronavirus: false seropositivity due to use of bacterially derived antigens. J. Virol. 80 (2006) 8920-8928
23. Li F.Q., Xiao H., Tam J.P., et al. Sumoylation of the nucleocapsid protein of severe acute respiratory syndrome coronavirus. FEBS Lett. 579 (2005) 2387-2396
24. Li Y.H., Li J., Liu X.E., et al. Detection of the nucleocapsid protein of severe acute respiratory syndrome coronavirus in serum: comparison with results of other viral markers. J. Virol. Methods 130 (2005) 45-50
25. Liang M.F., Du R.L., Liu J.Z., et al. SARS patients-derived human recombinant antibodies to S and M proteins efficiently neutralize SARS-coronavirus infectivity. Biomed. Environ. Sci. 18 (2005) 363-374
26. Liao Q.J., Ye L.B., Timani K.A., et al. Activation of NF-kappaB by the full-length nucleocapsid protein of the SARS coronavirus. Acta Biochim. Biophys. Sin. (Shanghai) 37 (2005) 607-612
27. Liu G., Hu S., Hu Y., et al. The C-terminal portion of the nucleocapsid protein demonstrates SARS-CoV antigenicity. Genom. Proteom. Bioinform. 1 (2003) 193-197
28. Liu R.S., Yang K.Y., Lin J., et al. High-yield expression of recombinant SARS coronavirus nucleocapsid protein in methylotrophic yeast Pichia pastoris. World J. Gastroenterol. 10 (2004) 3602-3607
29. Liu I.J., Chen P.J., Yeh S.H., et al. Immunofluorescence assay for detection of the nucleocapsid antigen of the severe acute respiratory syndrome (SARS)-associated coronavirus in cells derived from throat wash samples of patients with SARS. J. Clin. Microbiol. 43 (2005) 2444-2448
30. Liu S.J., Leng C.H., Lien S.P., et al. Immunological characterizations of the nucleocapsid protein based SARS vaccine candidates. Vaccine 24 (2006) 3100-3108
31. Luo C., Luo H., Zheng S., et al. Nucleocapsid protein of SARS coronavirus tightly binds to human cyclophilin A. Biochem. Biophys. Res. Commun. 321 (2004) 557-565
32. Luo H., Ye F., Sun T.Y., et al. In vitro biochemical and thermodynamic characterization of nucleocapsid protein of SARS. Biophys. Chem. 112 (2004) 15-25
33. Luo H., Ye F., Chen K., et al. SR-rich motif plays a pivotal role in recombinant SARS coronavirus nucleocapsid protein multimerization. Biochemistry 44 (2005) 15351-15358
34. Luo H., Chen Q., Chen J., et al. The nucleocapsid protein of SARS coronavirus has a high binding affinity to the human cellular heterogeneous nuclear ribonucleoprotein A1. FEBS Lett. 579 (2005) 2623-2628
35. Luo H., Chen J., Chen K., et al. Carboxyl terminus of severe acute respiratory syndrome coronavirus nucleocapsid protein: self-association analysis and nucleic acid binding characterization. Biochemistry 45 (2006) 11827-11835
36. Pang H., Liu Y., Han X., Xu Y., Jiang F., Wu D., Kong X., Bartlam M., and Rao Z. Protective humoral responses to severe acute respiratory syndrome-associated coronavirus: implications for the design of an effective protein-based vaccine. J. Gen. Virol. 85 (2004) 3109-3113
37. Pei H., Liu J., Cheng Y., et al. Expression of SARS-coronavirus nucleocapsid protein in Escherichia coli and Lactococcus lactis for serodiagnosis and mucosal vaccination. Appl. Microbiol. Biotechnol. 68 (2005) 220-227
38. Qiu M., Wang J., Wang H., Chen Z., Dai E., Guo Z., Wang X., Pang X., Fan B., Wen J., Wang J., and Yang R. Use of the COOH portion of the nucleocapsid protein in an antigen-capturing enzyme-linked immunosorbent assay for specific and sensitive detection of severe acute respiratory syndrome coronavirus. Clin. Diagn. Lab. Immunol. 12 (2005) 474-476
39. Rota P.A., Oberste M.S., Monroe S.S., et al. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 300 (2003) 1394-1399
40. Rowland R.R., Chauhan V., Fang Y., et al. Intracellular localization of the severe acute respiratory syndrome coronavirus nucleocapsid protein: absence of nucleolar accumulation during infection and after expression as a recombinant protein in vero cells. J. Virol. 79 (2005) 11507-11512
41. Saijo M., Ogino T., Taguchi F., et al. Recombinant nucleocapsid protein-based IgG enzyme-linked immunosorbent assay for the serological diagnosis of SARS. J. Virol. Methods 125 (2005) 181-186
42. Shang B., Wang X.Y., Yuan J.W., et al. Characterization and application of monoclonal antibodies against N protein of SARS-coronavirus. Biochem. Biophys. Res. Commun. 336 (2005) 110-117
43. Spiegel M., Pichlmair A., Martinez-Sobrido L., et al. Inhibition of beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3. J. Virol. 79 (2005) 2079-2086
44. Sun Z.F., and Meng X.J. Antigenic cross-reactivity between the nucleocapsid protein of severe acute respiratory syndrome (SARS) coronavirus and polyclonal antisera of antigenic group I animal coronaviruses: implication for SARS diagnosis. J. Clin. Microbiol. 42 5 (2004) 2351-2352
45. Surjit M., Liu B., Chow V.T., et al. The nucleocapsid protein of the SARS coronavirus is capable of self-association through a C-terminal 209 amino acid interaction domain. Biochem. Biophys. Res. Commun. 317 (2004) 1030-1036
46. Surjit M., Liu B., Jameel S., et al. The SARS coronavirus nucleocapsid protein induces actin reorganization and apoptosis in COS-1 cells in the absence of growth factors. Biochem. J. 383 (2004) 13-18
47. Surjit M., Liu B., Kumar P., et al. The nucleocapsid protein of the SARS coronavirus is capable of self-association through a C-terminal 209 amino acid interaction domain. Biochem. Biophys. Res. Commun. 317 (2004) 1030-1036
48. Surjit M., Kumar R., Mishra R.N., et al. The severe acute respiratory syndrome coronavirus nucleocapsid protein is phosphorylated and localizes in the cytoplasm by 14-3-3-mediated translocation. J. Virol. 79 (2005) 11476-11486
49. Surjit M., Liu B., Chow V.T., et al. The nucleocapsid protein of severe acute respiratory syndrome-coronavirus inhibits the activity of cyclin-cyclin-dependent kinase complex and blocks S phase progression in mammalian cells. J. Biol. Chem. 281 (2006) 10669-10681
50. Timani K.A., Liao Q., Ye L., et al. Nuclear/nucleolar localization properties of C-terminal nucleocapsid protein of SARS coronavirus. Virus Res. 114 (2005) 23-34
51. Tong S., Lingappa J.R., Chen Q., et al. Direct sequencing of SARS-coronavirus S and N genes from clinical specimens shows limited variation. J. Infect. Dis. 190 (2004) 1127-1131
52. Wang Y., Wu X., Wang Y., et al. Low stability of nucleocapsid protein in SARS virus. Biochemistry 43 (2004) 11103-11108
53. Wang Z., Yuan Z., Matsumoto M., et al. Immune responses with DNA vaccines encoded different gene fragments of severe acute respiratory syndrome coronavirus in BALB/c mice. Biochem. Biophys. Res. Commun. 327 (2005) 130-135
54. Woo P.C.Y., Lau S.K.P., Wong B.H.L., Chan K.H., Chu C.M., Tsoi H.W., Huang Y., Peiris J.S.M., and Yuen K.Y. Longitudinal profile of immunoglobulin G (IgG), IgM, and IgA antibodies against the severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in patients with pneumonia due to the SARS coronavirus. Clin. Diagn. Lab. Immunol. 11 (2004) 665-668
55. Woo P.C., Lau S.K., Wong B.H., et al. Differential sensitivities of severe acute respiratory syndrome (SARS) coronavirus spike polypeptide enzyme-linked immunosorbent assay (ELISA) and SARS coronavirus nucleocapsid protein ELISA for serodiagnosis of SARS coronavirus pneumonia. J. Clin. Microbiol. 43 (2005) 3054-3058
56. Yan X., Hao Q., Mu Y., et al. Nucleocapsid protein of SARS-CoV activates the expression of cyclooxygenase-2 by binding directly to regulatory elements for nuclear factor-kappa B and CCAAT/enhancer binding protein. Int. J. Biochem. Cell Biol. 38 (2006) 1417-1428
57. Yip C.W., Hon C.C., Zeng F., Chow K.Y., Chan K.H., Peiris J.S., and Leung F.C. Naturally occurring anti-Escherichia coli protein antibodies in the sera of healthy humans cause analytical interference in a recombinant nucleocapsid protein-based enzyme-linked immunosorbent assay for serodiagnosis of severe acute respiratory syndrome. Clin. Vaccine Immunol. 14 (2007) 99-101
58. You J., Dove B.K., Enjuanes L., et al. Subcellular localization of the severe acute respiratory syndrome coronavirus nucleocapsid protein. J. Gen. Virol. 86 (2005) 3303-3310
59. Yu I.M., Gustafson C.L., Diao J., et al. Recombinant severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein forms a dimer through its C-terminal domain. J. Biol. Chem. 280 (2005) 23280-23286
60. Yu I.M., Oldham M.L., Zhang J., et al. Crystal structure of the severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein dimerization domain reveals evolutionary linkage between corona- and arteriviridae. J. Biol. Chem. 281 (2006) 17134-17139
61. Yu F., Le M.Q., Inoue S., et al. Recombinant truncated nucleocapsid protein as antigen in a novel immunoglobulin M capture enzyme-linked immunosorbent assay for diagnosis of severe acute respiratory syndrome coronavirus infection. Clin. Vaccine Immunol. 14 (2007) 146-149
62. Zakhartchouk A.N., Viswanathan S., Mahony J.B., et al. Severe acute respiratory syndrome coronavirus nucleocapsid protein expressed by an adenovirus vector is phosphorylated and immunogenic in mice. J. Gen. Virol. 86 (2005) 211-215
63. Zhang L., Wei L., Jiang D., Wang J., Cong X., and Fei R. SARS-CoV nucleocapsid protein induced apoptosis of COS-1 mediated by the mitochondrial pathway. Artif. Cells Blood Substit. Immobil. Biotechnol. 35 (2007) 237-253
64. Zhao P., Cao J., Zhao L.J., et al. Immune responses against SARS-coronavirus nucleocapsid protein induced by DNA vaccine. Virology 331 (2004) 128-135
65. Zhao J., Huang Q., Wang W., Zhang Y., Lv P., and Gao X.-M. Identification and characterization of dominant helper T-cell epitopes in the nucleocapsid protein of severe acute respiratory syndrome coronavirus. J. Virol. 81 11 (2007) 6079-6088
66. Zheng B., He M.L., Wong K.L., et al. Potent inhibition of SARS-associated coronavirus (SCOV) infection and replication by type I interferons (IFNalpha/beta) but not by type II interferon (IFN-gamma). J. Interferon Cytokine Res. 24 (2004) 388-390
67. Zhu M.S., Pan Y., Chen H.Q., et al. Induction of SARS-nucleoprotein-specific immune response by use of DNA vaccine. Immunol. Lett. 92 (2004) 237-243